Home NDC 0002-7623 Alimta
Product NDC 0002-7623
11-digit product format 000027623
Labeler code 0002
Product ID 0002-7623_3af0bc84-13d6-46aa-a4c0-c62410b73bc6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Pemetrexed disodium
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Eli Lilly and Company
Application NDA021462
Marketing category NDA
Marketing start 2004-02-04
Substance PEMETREXED DISODIUM HEPTAHYDRATE
Active strength 500 mg/20mL
Pharmacologic classes Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021462-001 ALIMTA PEMETREXED DISODIUM EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 N021462-002 ALIMTA PEMETREXED DISODIUM EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2004-02-04 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS AP RLD, RS 2007-09-07 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2004-02-04 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2007-09-07 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2004-02-04 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2007-09-07 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2004-02-04 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2007-09-07 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021462-001 ALIMTA EQ 500MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2004-02-04 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021462-002 ALIMTA EQ 100MG BASE/VIAL POWDER / INTRAVENOUS RLD, RS 2007-09-07 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 60 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021462-001 7772209*PED 2022-05-24 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021462-002 7772209*PED 2022-05-24 Pediatric extension 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021462-001 7772209*PED 2022-05-24 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021462-002 7772209*PED 2022-05-24 Pediatric extension 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021462-001 7772209*PED 2022-05-24 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021462-002 7772209*PED 2022-05-24 Pediatric extension 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021462-001 7772209 2021-11-24 U-1296 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021462-001 7772209*PED 2022-05-24 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021462-002 7772209 2021-11-24 U-1296 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021462-002 7772209*PED 2022-05-24 Pediatric extension 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021462-001 7772209*PED 2022-05-24 Pediatric extension bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021462-002 7772209*PED 2022-05-24 Pediatric extension bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021462-001 7772209 2021-11-24 U-1296 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021462-001 7772209*PED 2022-05-24 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021462-002 7772209 2021-11-24 U-1296 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021462-002 7772209*PED 2022-05-24 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021462-001 7772209 2021-11-24 U-1296 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021462-001 7772209*PED 2022-05-24 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021462-002 7772209 2021-11-24 U-1296 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021462-002 7772209*PED 2022-05-24 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021462-001 7772209 2021-11-24 U-1296 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021462-001 7772209*PED 2022-05-24 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021462-002 7772209 2021-11-24 U-1296 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021462-002 7772209*PED 2022-05-24 Pediatric extension 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021462-001 7772209 2021-11-24 U-1296 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021462-001 7772209*PED 2022-05-24 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021462-002 7772209 2021-11-24 U-1296 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021462-002 7772209*PED 2022-05-24 Pediatric extension 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021462-001 7772209 2021-11-24 U-1296 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021462-001 7772209*PED 2022-05-24 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021462-002 7772209 2021-11-24 U-1296 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021462-002 7772209*PED 2022-05-24 Pediatric extension c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021462-001 7772209 2021-11-24 U-1296 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021462-001 7772209*PED 2022-05-24 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021462-002 7772209 2021-11-24 U-1296 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021462-002 7772209*PED 2022-05-24 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021462-001 7772209 2021-11-24 U-1296 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021462-001 7772209*PED 2022-05-24 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021462-002 7772209 2021-11-24 U-1296 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021462-002 7772209*PED 2022-05-24 Pediatric extension b00525d2431f…
Additional Listing Data#
Finished product Yes
Brand name base Alimta
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PEMETREXED DISODIUM HEPTAHYDRATE 500 mg/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9T47E4OM16 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1728072 Internal RxNorm lookup 1728075 Internal RxNorm lookup 1728077 Internal RxNorm lookup 1728079 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0002-7623-01 Alimta 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 59 0002-7623-01 Alimta 20 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 20 59
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Pemetrexed disodium heptahydrate ACTIVE INGREDIENT 9T47E4OM16 ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 43 Pemetrexed ACTIVE MOIETY 04Q9AIZ7NO ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 43 Hydrochloric acid INACTIVE INGREDIENT QTT17582CB ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 43 Mannitol INACTIVE INGREDIENT 3OWL53L36A ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 43 Sodium hydroxide INACTIVE INGREDIENT 55X04QC32I ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 43
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0002-7623 ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] 59 Current NDC, Legacy NDC, 2 package rows 20230628_f5a860f3-37ec-429c-ae04-9c88d7c55c08.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0002-7623-01 00002762301 1 VIAL in 1 CARTON (0002-7623-01) / 20 mL in 1 VIAL 1 vial 2004-02-13 0000-00-00 No No Current